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In the three years between November 1989 and October 1992, an outbreak ofmethicil- 
lin-resistant Staphylococcus aureus (MRSA) affected 990 patients at a university 
hospital. The distribution of patients with carriage, colonization or infection was inves- 
tigated prospectively. Nosocomial acquisition was confirmed in at least 928 patients, 
525 of whom were identified from clinical specimens as being infected (n = 418) or 
colonized (n = 107) by MRSA. An additional 403 patients were identified from screen- 
ing specimens, of whom 58 subsequently became infected and 18 colonized. Screening 
of the nose, throat and perineum detected 98 % of all carriers. Of the 580 infections in 
476 patients, surgical wound, urinary tract and skin infections accounted for 58 % of 
the infections. Of the 476 infected patients, death was attributable to MRSA infection 
in 13 %. Colonization with MRSA was found in 127 patients and 42 % of 165 
colonized sites were the skin. Auto-infection from nasal carriage or cross-infection, 
probably via staff hands, seemed to be the most common mode of acquisition of 
MRSA infections. 
The increasing incidence, worldwide, of noso- 
comial infection caused by methicillin-resistant 
Staphylococcus aureus (MRSA) in the late 1970s 
and in the 1980s (1-8) often resulted from exten- 
sive hospital outbreaks (9-16). The first outbreak 
of MRSA was not described in Spain until 1981 
(17). The prevalence ofMRSA remained low (18) 
until recently, when MRSA became an epidemic 
problem in several hospitals (19-21) and a new 
phage type was identified amongst MRSA iso- 
lates from several Spanish hospitals (22). At the 
Hospital Universitario San Carlos in Madrid, 
MRSA was not a problem until November 1989, 
when a large outbreak that ultimately affected 
more than 900 patients began. 
Despite many other published studies of MRSA 
outbreaks, there are still uncertainties about the 
number of carriers and colonized patients com- 
pared with the number of clinically infected 
patients; furthermore, there seems to be no con- 
clusive data about the sensitivities and negative 
predictive values of the various combinations of 
screening specimens. We therefore investigated 
prospectively the distribution of patients with 
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carriage, colonization or infection in a large 
hospital outbreak. 
Materials and Methods 
Hospital. The Hospital Universitario San Carlos is a 1500- 
bed teaching hospital with all major specialities and 
serves a population of 600,000. It has a 32-bed intensive 
care unit and three surgical recovery units with 28 beds. 
Wards of 18 beds contain mostly six-bed rooms, although 
several double-bed rooms arc interspersed. The average 
nurse-to-patient ra io on the general wards is 1:18. 
Surveillance Programme. I atients with MRSA were iden- 
tified from clinical specimens, with results reported aily 
from the diagnostic microbiology laboratory. All patients 
were entered into a prospective surveillance programme 
and followed up until discharge from the hospital. 
Microbiological testing of clinical specimens usually iden- 
tifies only those patients infected with MRSA and those 
with MRSA in clinical lesions. In this study we identified, 
in addition, those patients with MRSA at the recognized 
staphylococcal carriage sites by an active screening pro- 
gramme that was started in November 1990. We therefore 
defined a patient with MRSA as one from whom MRSA 
had been isolated on one or more occasions from any 
body site. Infections with MRSA were defined according 
to the Centers for Disease Control (CDC) standard defi- 
nitions (23). Carriers were patients from whom MRSA 
was isolated from one or more normal carrier sites, i.e. 
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from the anterior nares, throat, perineum, groin or axilla. 
Colonized patients were defined as those without clinical 
~ mptoms who harboured MRSA at non-carriage sites. pital-acquired MRSA was defined as the isolation of 
SA 48 h or more after hospital admission from 
patients without previous hospitalization. Relapse was 
defined as a new episode of MRSA infection or a new 
episode of colonization or carriage in a patient who had 
had at least hree specimens that were previously negative 
for MRSA. 
Information on each patient was collected prospectively 
and included the patient's registration data, the day of 
MRSA acquisition, the dates and sites of all positive 
cultures, the location of the patient in the hospital at the 
time of MRSA isolation, and his or her exposure to 
topical and systemic anti-staphylococcal treatment. 
Microbiological Methods. MRSA was isolated and iden- 
tified by standard microbiological methods that included 
esting for methicillin resistance by a controlled isk dif- 
Usion method on Mueiler-Hinton agar plates that were 
Incubated for 24 h at 35 *C. Phage typing of 188 screening 
isolates was performed by standard methods (24) at the 
Instituto Carlos III, Madrid, Spain. Phage typing of 
selected isolates with experimental phages was carried 
ut by the Staphylococcus Reference Laboratory of the 
entral Public Health Laboratory, London, England (22). 
Control Measures. From November 1990, the programme 
for the control of MRSA was a local modification of the 
UK Guidelines for the control of MRSA (25) and will 
be described in full elsewhere. These guidelines include 
the prompt identification of patient and staff carriers by 
screening, the elimination of nasal carriage with in- 
tranasal mupirocin applied three times a day for five to 
seven days and the use of topical antiseptics uch as 
chlorexidine to other positive skin sites. 
Results 
Outbreak. The first patient with MRSA infection 
was detected in July 1989. By October 1992 
MRSA had been isolated from 1,074 patients. 
Eighty-four (7.8 %) were re-infected, re-colo- 
nized or were re-admissions known to have had 
MRSA previously. Of  the 990 patients with newly 
acquired MRSA,  928 (93.7 %) acquired the or- 
ganism after admission. Eleven patients had 
MRSA at the time of their hospital admission; for 
51 patients who had previous hospitalization it
was not possible to define the time of acquisition. 
The index case probably initiated the outbreak in 
November  1989. She was a neurosurgical patient 
who had been infected and colonized with MRSA 
and transferred through several hospital depart- 
ments, including the intensive care unit. From 
50 
~- 45 
0 
~40 
t -  
O 
3o 
~25 
Q 
0 
~20 
I,l 
- 5 
0 
m INFECTED 
[ ]  NASAL CARRIER 
[ ]  COLONIZED/CARRIER AT NON NASAL SITES 
JASONDJ  FMAMJ JASONDJ  FMAMJ JASONDJ  FMAMJ JASOND 
I 89 ! I 90 ! .  91 I 92 11 
~Nasa l  muplroc~n + antiseptics to skin - -  
L Screening + isolation + follow-up _3 
Figure 1: Epidemic urve showing the incidence of MRSA infection, nasal carriage, and carriage 
and colonization at other sites before and after an active screening programme. 
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November 1989, MRSA spread rapidly through- 
out the hospital and affected 12 of 13 medical and 
8 of 10 surgical departments. 
Methicillin-resistant Staphylococcus attreus was 
identified from clinical specimens in 525 pa!ients 
(418 infected and 107 colonized), and an addi- 
tional 403 patients (43.4 % of the outbreak) were 
identified from screening specimens, ofwhom 58 
subsequently became infected and 18 colonized. 
The antibiograms for the MRSA isolates usually 
indicated sensitivity only to vancomycin, trime- 
thoprim, chloramphenicol, fosfomycin, fusidic 
acid and mupirocin. Of 188 strains isolated from 
screening specimens, 6 % belonged to phage 
group III and 94 % were non-typable with stand- 
ard phages. Using experimental phages, a new 
phage type 29/77/84/932 was identified amongst 
86 % of 29 strains from staff carriers and from 
patients who were infected, colonized or carriers. 
Table 1" Distribution by service of 928 new patients with 
hospital-acquired MRSA. 
Cumulative incidence 
per 1,000 admissions 
Service No. of Infected Colonized 
admissions or carrier 
Vascular surgery 1,514 17.2 21.1 
Geriatrics 1,578 10.8 13.9 
General surgery 9,270 10.6 8.8 
Intensive care unit 5,739 9.4 4.7 
Urology 2,190 8.7 14.1 
Internal medicine 17,047 8.6 10.6 
Orthopaedics 4,787 7.5 6.5 
Gastroenterology 2,749 6.9 4.0 
Other 34,085 5.5 3.2 
Table 2: Distribution ofMRSA infection and colonization 
bysite. 
Percent MRSA isolated from 
sites of infection or colonization 
Infection Colo- Total 
Site (n = 580) nization (n = 745) 
(n = 165) 
Surgical wound 22.1 20.0 21.6 
Urinary tract 19.1 20.6 19.5 
Skin 17.2 42.4 22.8 
Blood 15.7 - 12.2 
Lower espiratory tract 14.0 12.1 13.6 
Faeces 4.1 - 3.2 
Intravenous catheter 3.8 3.0 3.6 
Others 4.0 1.9 3.5 
The epidemic urve is shown in Figure 1. The 
peak of the outbreak was in November 1990, with 
a cumulative incidence of 17.4 new infected 
patients per 1,000 admissions per month, At this 
time we started the active screening programme 
and identified many more carriers. The cumula- 
tive incidence was found to be 20.4 nasal carriers 
per 1,000 admissions and 4.7 colonized patients or 
carriers at non-nasal sites per 1,000 admissions. 
By October 1992 the cumulative incidence of in- 
fected patients and nasal carriers was reduced to 
3.9 and 3.5 per 1,000 admissions, respectively. By 
March 1993 the cumulative incidence was less 
than 3 infected patients per 1,000 admissions per 
month. 
During the outbreak MRSA spread widely 
throughout the hospital. The intensive care unit 
and the entire surgical department had higher cu- 
mulative incidences of infection (9.4 and 7.1 per 
1,000 admissions, respectively) than the medical 
departments (6.5 infected patients per 1,000 ad- 
missions). Table 1 shows that the distribution f 
infected and colonized patients and carriers 
varied between the individual medical and surgi- 
cal departments. Vascular surgery had the 
greatest cumulative incidence of infected and 
colonized patients, followed by geriatrics. 
Patient Characteristics. Of 928 new patients with 
hospital-acquired MRSA, 576 were male and 352 
female. Seventy percent of the patients were > 60 
years of age. Ages ranged from 3 to 99 years, with 
a mean of 68.6 -+ 17.2 years. The mean length of 
hospital stay was 78.9 -+ 106.4 days, with a range of 
4-1,190 days. Infection by MRSA was thought to
be the cause of death in 13 % of the 476 infected 
patients. Of 928 patients with MRSA, 53 relapsed 
(22 infected patients, 5 colonized patients and 26 
carriers). 
Clinical Infections. There were 580 infections in 
476 patients, and 124 patients were colonized. 
Twenty-one percent of the patients had more than 
one positive site. Primary or secondary bacter- 
aemia accounted for 15.7 % of the infections. 
MRSA was isolated most frequently from the 
skin, surgical wounds and urinary tract, which to- 
gether accounted for 58 % of the infections 
(Table 2). MRSA colonized the skin in 42.4 % of 
the colonized sites, with bedsores accounting for 
78 % of the skin colonization. 
Screening Results. Table 3 shows the distribution 
of MRSA amongst the carriage sites of patients 
who were carriers, colonized or infected. The 
nose was the most common carriage site of 
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Tab le  3: Distribution of MRSA carriage by site. 
Patient group 
Nose 
S i te  
Throat Perineum Groin Axilla Total 
Carriers 
No. screened 403 
Percent positive in first sample 83.9 
Percent positive in subsequent samples 4.5 
Colonized 
No. screened 63 
Percent positive in first sample 32.2 
Percent positive in subsequent samples 6.3 
Infected 
No. screened 323 
Percent positive in first sample 37.5 
Percent positive in subsequent samples 9.0 
289 378 262 188 403 
30.8 38.1 15.6 10.1 100.0 
10.4 5.6 6.5 1.1 - 
56 57 57 55 63 
14.3 28.1 21.1 9.1 44.4 
5.4 12.3 8.8 1.8 9.5 
291 288 301 276 323 
27.1 22.6 15.0 10.5 55.4 
12.4 12.5 9.6 2.5 11.8 
Tab le  4: Patterns of 181 MRSA carriers detected with five 
screening swabs. 
Screening pattern No. (%) of 
------- patients 
Nose Throat Perineum Groin Axilla 
+ . . . .  62 (34.2) 
+ + _ - - 23 (12.7) 
+ - + - - 23 (12.7) 
+ + + - - 9 (5.0) 
+ + + + - 3 (1.7) 
+ + _ + - 3 (1.7) 
+ + _ - + 2(1.1) 
+ + + + + 2(1.1) 
+ and other patterns 15 (8.3) 
- - + - - 18  (9 .9 )  
- + _ _ - 9 (5 .0 )  
- + + - - 3 (1 .7 )  
Other patterns 9 (5.0) 
MRSA in infected and colonized patients and in 
carriers, but the frequency of nasal carriage 
Varied from 84 % in the carriers to 37 % and 32 % 
tn the infected and colonized groups, respectively. 
After the nose, the throat or perineum was the 
most frequent site for MRSA carriage but were 
more often positive in non-infected asympto- 
matic carriers. Fifty-five percent of infected 
Patients and 44 % of colonized patients were 
found to have  MRSA at one  or  more  o f  the  car-  
r iage sites on the first screening. Subsequent 
SCreening samples yielded further positive car- 
rtage sites in both infected and colonized patients. 
Tab le  5:  Sensitivities and negative predictive alues of 
MRSA screening samples. 
Samples Sensitivity Negative 
(%) predictive 
value (%) 
Nose alone 78.5 95.3 
Nose and throat 85.6 96.8 
Nose and perineum 93.4 98.5 
Nose, throat and perineum 98.3 99.6 
Thirty-three percent of infected patients and 46 % 
of colonized patients were always negative for 
MRSA carriage. 
Table 4 shows the patterns of MRSA carriage in 
181 non-infected asymptomatic carriers, all of 
whom were sampled at all five carriage sites, i.e. 
nose, throat, perineum, groin and axilla. The most 
frequent positive specimens were nose alone 
(34.2 %) or nose in combination with the throat 
or perineum (12.7 %). The perineum alone was 
positive in 9.9 % of the carriers and throat alone 
in 5%. The sensitivities and the negative predic- 
tive values of the screening samples for MRSA 
carriage in 975 patients are shown in Table 5. 
Nasal swabs alone would have identified 78.5 % 
of the carriers. The inclusion of throat and per- 
ineum samples would have increased the sensitiv- 
ity to 85.6 % and 93.4 %, respectively. Nose, 
throat and perineum swabs would have identified 
98.3 % of the carriers, with a negative predictive 
value of 99.6 % (Table 5). 
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Of 2,303 screening swabs from hospital staff, 
MRSA was isolated from the nose in 72 staff 
members on 84 occasions, giving a prevalence of 
3.6 %. The greatest prevalence was found during 
the final quarter of 1990, coinciding with the peak 
of the outbreak. 
Discussion 
Since 1989, the rate of isolation of MRSA in Spain 
has increased (18-21) and a new phage type 
29/77/84/932 has been identified amongst MRSA 
isolates from several Spanish hospitals (22). This 
particular strain of MRSA, the "Spanish strain", 
has similarities, including epidemicity, to 
EMRSA-1, described in the UK (6, 22, 26). 
Spanish MRSA was identified in our hospital and 
spread readily to most of the medical and surgical 
departments and caused alarge hospital outbreak 
that affected more than 900 patients over a three- 
year period. This supports the view that certain 
MRSA strains have enhanced transmissibility (3, 
4, 27, 28, 29). 
The widespread distribution of MRSA within the 
hospital could be related to the transfer of 
patients and staff between several hospital de- 
partments. Infection, colonization or carriage oc- 
curred on almost all clinical services and varied 
between different departments in the hospital. In 
our experience, as other authors have found (12, 
13, 20, 21, 30-33), surgical services and intensive 
care units had the greatest cumulative incidence 
of infection. The high incidence of infection in the 
geriatrics department may be explained by the 
high susceptibility of these patients to hospital- 
acquired infection, the severity of their underly- 
ing disease, the presence of decubitus ulcers, the 
use of medical devices and the multiple hospital 
admissions. 
The hospital reservoir of MRSA includes in- 
fected and colonized patients, patient carriers, 
staff carriers and, possibly, the inanimate hospital 
environment (3, 13, 33, 34). In this outbreak an 
active screening programme identified an addi- 
tional 403 new asymptomatic carriers (43 % of 
the total outbreak) who would not have been de- 
tected by clinical specimens. Identification and 
treatment of these carriers coincided exactly with 
the reduction in the number of newly infected 
patients and the control f the outbreak. This 
confirms the importance ofas vmptomatic MRSA 
carriers as a source of MRSA that sustains the 
outbreak by continuing cross-infection (35). 
Several studies have shown that MRSA strains 
are at least as pathogenic as methicillin-sensitive 
strains (8, 12, 13, 30). From the xperience of the 
1980s it seems clear that MRSA can cause signifi- 
cant morbidity and mortality (36, 37). We found 
that more than two-thirds of the patients with 
MRSA who were identified by clinical specimens 
had clinical infection. Post-operative wound in- 
fections and skin infections accounted for nearly 
40 % of total MRSA infection, as found by other 
authors (10, 30, 38). Although bacteriuria caused 
by Staphylococcus aureus is infrequent, we found 
the urinary tract to be the second most common 
site of MRSA infection and colonization. We 
believe that the high frequency of MRSA bacteri- 
uria in our study could be explained by the high 
proportion of patients with urinary tract catheters 
(more than 60 %), underlying urology disorders 
or urologic manipulation. These risk factors have 
been suggested by other workers (39). The high 
frequency of bacteraemia (15.7 % of 476 MRSA 
infections) and the number of deaths associated 
with MRSA infections (13 %) leave no doubt hat 
our strain of MRSA was truly pathogenic. 
The skin was the most common site of coloniza- 
tion. Skin colonization occurred mostly in older 
patients with decubitus ulcers who had persistent 
colonization and were unable to leave the hospi- 
tal because of their poor functional status. This 
population provides a persistent reservoir of 
MRSA (40, 41). 
Early studies in the 1960s howed that nasal car- 
riage of Staphylococcus aureus by patients or staff 
provides asource of organisms for the acquisition 
of Staphylococcus aureus by other patients (42- 
46). It has also been known for many years that 
surgical patients who are nasal carriers of Staphy- 
lococcus aureus are more likely to acquire post- 
operative staphylococcal wound infection (47). 
We found that more than 50 % of the MRSA-in- 
fected patients also yielded MRSA from one or 
more carriage sites that could have been the 
source of MRSA for auto-infection. Thirty-seven 
of the infected patients, for example, carried 
MRSA in their anterior nares, where staphylo- 
cocci are known to provide the source of or- 
ganisms for auto-infection (35, 48). In contrast, 
one-third of the infected patients and nearly half 
of the colonized patients were consistently nega- 
tive for MRSA carriage, independent of the num- 
ber of samples and sites screened, a finding that is 
in agreement with other authors (49). This sug- 
gests that nasal acquisition does not always 
precede the isolation of the organism from clinical 
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specimens. In these patients it seems that their 
cross-infection via staff hands may have occurred 
through portals of entry such as damaged skin, 
urinary tract or intravascular devices (50). The 
number of nasal carriers amongst hospital staff 
seemed to be related to the prevalence ofpatients 
with MRSA, with a peak in the final quarter of 
1990 that coincided with the peak of the outbreak 
(sa). 
Although the nose is the most frequent carriage 
site for Staphylococcus aureus, several other skin 
carriage sites have been described (34, 44). We 
screened five different carriage sites in 181 non- 
infected asymptomatic carriers. The most com- 
mon positive carriage site was the nose alone 
(34 %) or the nose in combination with other 
screening sites (78.5 %). Perineal carriage alone 
was found in 9.9 % of the patients. Although in- 
frequent, perineal carriage could be important, as 
there is some evidence that perineal carriers are 
more likely to be dispersers (35). Throat carriage 
alone was found in only 5 % of the patients but 
Could be a source of MRSA for the re-coloniza- 
tion of the anterior nares, as suggested by Solberg 
(52). 
It is not clear from the literature which screening 
Samples are required to identify MRSA carriers. 
In this study we evaluated the sensitivities and 
negative predictive values of the different screen- 
ing samples for MRSA carriage and found that 
examination of nose, throat and perineum 
Samples from each patient identified almost all 
carriers. As it is usually necessary to limit the 
number of screening specimens, we have decided 
from our results to screen nose and perineum 
Samples, which would identify 93.4 % of carriers, 
and to take nose, perineum attd throat swabs for 
following up patients after anti-staphylococcal 
topical treatment. 
We COnclude that our MRSA strain spread easily 
and was pathogenic. An active screening pro- 
.gramme identified more than 40 % of the patients 
tn an MRSA outbreak and was significantly as- 
sociated with subsequent control of the outbreak. 
Acknowledgement 
We thank Prof. M.W. Casewell, King's College School of 
Medicine and Dentistry, London, for his review of the 
~nagUscript; Dr. A. Vindel, Instituto Carlos III, Madrid, 
Lo~r .  R. Marplcs, Public Health Laboratory Service, 
fn"~uon, tor the phage typing; and E Uribe and P. S,'inchez 
v, tecnnical assis " ' " o of the lance with the mtcroblol gy 
screening specimens. 
References 
1. Haley RW, Hightower AW, Khabbaz RF, Tbornsberry 
C, Martone W J, Allen JR, Hughes JM: The emergence 
of methieillin-resistant Staphylococcus aureus infec- 
tions in United States hospitals. Annals of Internal 
Medicine 1982, 97: 297-308. 
2. Boyee JM, Causey WA: Increasing occurrence of 
methicillin-resistant Staphylococcus aureus in the 
United States. Infection Control 1982, 3: 377-382. 
3. Casewell MW: Epidemiology and control of the "mod- 
ern" methicillin-resistant Staphylococcus aureus. Jour- 
nal of Hospital Infection 1986, 7, Supplement A: 1-11. 
4. Pavillard R, Harvey K, Douglas D, Hewstone A, An- 
drew J, Collopy B, Asche V, Carson P, Davidson A, 
Gilbert G, Spider J, Tosoline F: Epidemic of hospi- 
tal-acquired infection due to methicillin resistant 
Staphylococcus aureus in major Victorian hospitals. 
Medical Journal of Australia 1982, 1: 451---454. 
5. Jepsen OB: The demise of the old methieillin-resistant 
Staphylococcus aureus. Journal of Hospital Infection 
1986, 7, Supplement A: 13-17. 
6. MaqJles RR, Cooke EM: Current problems with 
methicillin-resistant Staphylococcus aureus. Journal of 
Hospital Infection 1988, 11: 381-392. 
7. Morgan MG, Harte-Barry M J: Methicillin-resistant 
Staphylococcus aureus: a ten year survey in a Dublin 
hospital. Journal of Hospital Infection 1989, 14: 357- 
362. 
8. French GL, Cheng AFB, Ling JML, Mo P, Donnan 
S: Hong Kong strains of methicillin-resistant and 
methicillin-sensitive Staphylococcus aureus have sim- 
ilar virulence. Journal of Hospital Infection 1990, 15: 
117-125. 
9. Shanson DC, Ken~t JG, Duke R: Outbreak of hospital 
infection with a strain of Staphylococcus aureus re- 
sistant o gentamicin and methicillin. Lancet 1976, ii: 
1347-1348. 
10. Crossley K, Loesch D, Landesman B, Mead K, Chern 
M, Strate R: An outbreak of infections caused by 
strains of Staphylococcus aureus resistant to methieillin 
and aminoglycosides. Clinical studies. Journal of In- 
fectious Diseases 1979, 139: 273-279. 
11. Cromley K, Landesman B, Zaske D: An outbreak of 
infections caused by strains of Staphylococcus aureus 
resistant to methicillin and aminoglycosides. Epidemi- 
ologic studies. Journal of Infectious Diseases 1979, 139: 
280-287. 
12. Peacock JE Jr, Marsik FJ, Wenzel RP: Methicillin- 
Tesistant Staphylococcus aureus introduction and 
spread within a hospital. Annals of Internal Medicine 
1980, 93: 526-532. 
13. Thompson RL, Cabezudo i, Wenzel RP: Epidcmiology 
of nosocomial infections caused by methieillin-re- 
sistant Staphylococcus aureus. Annals of Internal Med- 
icine 1982, 97: 309-317. 
14. Linnemann CC Jr, Mason M, Moore P, Korfhagen 
TR, Slaneck JL: Methicillin-resistant Staphylococcus 
aureus: experience in a general hospital over four 
years. American Journal of Epidcmiology 1982, 115: 
941-950. 
15. Duckworth G J, Lolhlan JLE, Wiilians JD: Methicil- 
lin-resistant Staphylococcus aureus: report of an out- 
break in a London teaching hospital. Journal of Hospi- 
tal Infection 1988, 11: 1-15. 
80 Eur.  J. Ciin. Microbia l .  Infect. Dis. 
16. Vandenbroucke-Grauis CM, Frrnay HME, van Kling- 
eren B, Savekoul TF, Verhoef J: Control of epidemic 
methicillin-resistant Staphylococcus aureus in a Dutch 
University Hospital. European Journal of Clinical Mi- 
crobiology and Infectious Diseases 1991, 10: 6-1L 
17. Pfirez Trallero E, Garda Arenzana J, Ansa Castafieda 
A, Palsan Grisolia L: Unusual multiresistant S aphy- 
lococcus aureus in a newborn ursery. American Jour- 
nal of Diseases of Children 1981, 135: 689--692. 
18. Bouza E, Martinez-Beltr~in J, Grupo de Trabajo para 
el estudio de estafilococos: Estudio multicrntrico sabre 
la prevalencia de estafilococos en Espafia. (Informe 
preliminar). Enfermedades Infecciosas y Microbiolo- 
gfa Clfnica 1988, 6: 68-79. 
19. Rodriguez-Creixems M: Evoluci6n de la resistencia 
a antimicrobianos destaphylococcus ai lados en hospi- 
tales espafioles. Enfermedades Infecciosas y Micro- 
biologia Clfnica 1992, 10, Suplemento 3: 24-29. 
20. Parras F, Rodriguez M, Bou~.a E, Mufioz P, Cercenado 
E, Guerrero C, Zancada G: Brote epid6mico de 
Staphylococcus aureus resistente a meticilina (SARM) 
cn un hospital general. Informe preliminar. Enfer- 
medades Infecciosas y Microbiologfa Clfnica 1991, 9: 
200-207. 
21. Trilla A, Marco F, Moreno A, Prat A, Soriano E, Ji- 
mrnez de Anta MT, Comit6 de Control de Infecciones: 
Epidemilogfa clfnica de un brote de infecci6n noso- 
comial par Staphylococcus aureus resistente a meti- 
cilina y aminoglucrsidos eficacia de las medidas de 
control. Medicina Clfnica (Barcelona) 1993, 100: 205- 
209. 
22. Aparieio P, Richardson J, Martin S, Vindel A, Marples 
RR, Cookson BD: An epidemic methicillin-resistant 
strain of Staphylococcus aureus in Spain. Epidemiology 
of Infection 1992, 108: 287-298. 
23. Garner JS, Jar/is WR, Emori TG, Horan TC Hughes 
JM: CDC definitions for nosocomial infections, 1988. 
American Journal of Infection Control 1988, 16: 128- 
140. 
24. Blair JE, Willians REO: Phage typing ofstaphylococei. 
Bulletin of the World Health Organization 1961, 24: 
771-784. 
25. Working Party of the Hospital Infection Society and 
British Society for Antimicrobial Chemotherapy: Re- 
vised guidelines for the control of epidemic methi- 
cillin-resistant Staphylococcus aureus. Journal of 
Hospital Infection 1990, 16: 351-377. 
26. Kerr S, Kerr GE, Mackintosh CA, Marples RR: A 
survey of methicillin-resistant Staphylococcus aureus 
in England and Wales. Journal of Hospital Infection 
1990, 16: 35-48. 
27. Townsend DE, Ashdown N, Boiton S, Bradley J, 
Duckworth G, Moorhouse EC, Grubb WB: The in- 
ternational spread of methicillin-resistant Staphylococ- 
cus aureus. Journal of Hospital Infection 1987, 9: 60-71. 
28. Phillips I: Epidemicity of methicillin-resistant Staphy- 
lococcus aureus. In: Coello R, Casewell MW (ed): 
Methicillin-resistant S aphylococcus aureus. Wells 
Medical, Tunbridge Wells, UK 1993, p. 29-32. 
29. Cookson liD, Phillips I: Epidemic methicillin-resistant 
Staphylococcus aureus. Journal of Antimicrobial 
Chemotherapy 1988, 24, Supplement C: 57--65. 
30. l|oyce JM, Landry M, Deetz TR, DuPont HL: Epi- 
demiologic studies of an outbreak of nosoeomial 
mcthicillin-resistant Staphylococcus aureus infections. 
Infection Control 1981, 2: 110--116. 
31. Locksley RM, Cohen ML, Quinn TC, Tompkins LS, 
Coyle MB, Kirihara JM, Counts GW: Multiply anti- 
biotic-resistant S aphylococcus aureus introduction, 
transmission and evolution of nosocomial infection. 
Annals of Internal Medicine 1982, 97: 317-324. 
32. Craven DE, Reed C, Kolllsch N, DeMaria A, 
Lichtenberg D, Shen K, McCabe WR: A large out- 
break of infections caused by a strain of Staphylococcus 
aureus resistant o oxacillin and aminoglycosides. 
American Journal of Medicine 1981, 71: 53-58. 
33. Bartzokas CA, Paton JH, Gibson MF, Graham R, 
McLoughlin GA, Croton RS: Control and eradication 
of methicillin-resistant Staphylococcus aureus on a sur- 
gical unit. New England Journal of Medicine 1984, 
311: 1422-1425. 
34. Wenzel RP, Nettleman MD, Jones RN, Pfaller MD: 
Methicillin-resistant Staphylococcus aureus implica- 
tions for the 1990s and effective control measures. 
American Journal of Medicine 1991, 91, Supplement 
3B: 221-227. 
35. Casewell MW, Hill RLR: The carrier state: mcthicil- 
lin-resistant Staphylococcus aureus. Journal of An- 
timicrobial Chemotherapy 1986, 18, Supplement A: 
1-12. 
36. Keane CT, Cafferkey MT: Re-emergence of methi- 
cillin-resistant S aphylococcus aureus causing severe 
infections. Journal of Infection 1984, 9: 6-16. 
37. Myers JP, Linneman CC, Jr:. Bacteremia due to methi- 
cillin-resistant S aphylococcus aureus. Journal of In- 
fectious Diseases 1982, 145: 532-536. 
38. Klimek J J, Marsik FJ, Bartlett RC, Weir B, Shea P, 
Quintiliani R: Clinical, epidemiologic and bacterio- 
logic observations of an outbreak of methicillin-re- 
sistant Staphylococcus aureus at a large community 
hospital. American Journal of Medicine 1976, 61: 340- 
345. 
39. Sapico FL, Montgomerie JZ, Canawati HN, Aeilts G: 
Methicillin-resistant S aphylococcus aureus bacteri- 
uria. American Journal of the Medical Sciences 1981, 
281: 101-109. 
40. Murray-Leisure KA, Geib S, Graceley D, Rubin-Slut- 
sky AB, Saxena N, Muller HA, Hamory BH: Control 
of epidemic methicillin-resistant Staphylococcus 
aureus. Infection Control and Hospital Epidemiology 
1990, 11: 343-350. 
41. Bradley Sl c, Terpenning MS, Ramsey MA, Zarins LT, 
Jorgensen KA, Sottile WS, Schaberg DR, Kauffman 
CA: Mcthicillin-resistant Staphylococcus aureus: 
colonization and infection in a long-term care facility. 
Annals of Internal Medicine 1991, 115: 417-422. 
42. White A: Relation between quantitative nasal cultures 
and dissemination f staphylococci. Journal of Labora- 
tory and Clinical Medicine 1961, 58: 273-277. 
43. Lidweli OM, Polakoff S, Jevons MP, Parker MT, 
Shooter RA, French VI, Duhkerley DR: Staphylo- 
coccal infection in thoracic surgery: experience in a 
subdivided ward. Journal of Hygiene (Cambridge) 
1966, 64: 321-337. 
44. Williams REO: Healthy carriage of Staphylococcus 
aureus: its prevalence and importance. Bacteriological 
Reviews 1963, 27: 56-71. 
45. Lidwell OM, Polakoff S, Davies J, Hewitt JH, Shooter 
RA, Walker KA, Gaya H, Taylor GW: Nasal acqui- 
sition of Staphylococcus aureus in a subdivided and 
mechanically ventilated ward: endemic prevalence of 
a single staphylococcal strain. Journal of Hygiene 
(Cambridge)1970, 68: 417-433. 
Vol. 13, 1994 81 
46. Lidwell OM, Davies J, Payne RW, Newman P, Wil- 
liams REO: Nasal acquisition of Staphylococcus aureus 
in partly divided wards. Journal of Hygiene (Cam- 
bridge) 1971, 69: 113-123. RA Hunter CJW. 
47. Williams REO, Jevons MP, Shooter , 
Girling JA, Griffiths JD, Taylor GW: Nasal staphy- 
lococci and sepsis in hospital patients. British Medical 
Journal 1959, 2: 658--662. 
48. Caseweil MW, Hill RLR: Minimal dose requirements 
for nasal mupirocin and its role in the control of epi- 
demic MRSA. Journal of Hospital Infection 1991, 19, 
Supplement B: 35-40. 
49. Rimland D, Roberson B: Gastrointestinal c rriage of 
methicillin-resistant Staphylococcus aureus. Journal of 
Clinical Microbiology 1986, 24: 137-138. 
50. Cookson BD, Peters B, Webster M, Phillips 1, Rahman 
M, Noble W: Staff carriage of epidemic methicillin- 
resistant Staphylococcus aureus. Journal of Clinical Mi- 
crobiology 1989, 27: 1471-1476. 
51. Gaspar MC, Uribe P, Sdnchez P, Coeilo R, Cruzet 
F: Personal hospitalario portador nasal de Staphylo- 
coccus aureus resistente a meticilina. Utilidad del 
tratamiento con mupirocina. Enfermedades Infec- 
ciosas y Microbiologfa Clfnica 1992, 0: 107-110. 
52. Soiberg CO: A study of carriers of Staphylococcus 
aureus. Acta Medica Seandinaviea 1965, 178, Supple- 
ment: 436. 
